The University of Notre Dame Australia - Study Abroad

Bachelor of Laws / Bachelor of Biomedical Science

The University of Notre Dame Australia - Study Abroad

Type of institution: University/Higher Education Institution
Level: Undergraduate
CRICOS: 01032F

The Bachelor of Laws degree provides a gateway to a rewarding career in Law and can provide a strong foundation for other career opportunities. This degree will prepare you to work as a lawyer in a private practice, in government, as corporate counsel or in a not-for-profit organisation. A Biomedical Science course at Notre Dame is a gateway to a rewarding career in a host of health-related fields and it also provides the foundation for advanced scientific investigations. This course includes a general introduction to biological science plus coverage of such topics as anatomy, molecular and cell biology, microbiology, immunology, biochemistry, genetics, pathology, forensic science, human physiology, neuroscience and reproductive biology. The course includes a compulsory liberal arts component through the core curriculum, comprising foundations courses of philosophy, theology and ethics.


  • 3 core curriculum courses
  • 23 compulsory law courses
  • 4 law elective courses
  • 14 biomedical science courses


  • Biomedical science
  • Law

Standard entry requirements

  • Applicant with recent Secondary Education - Indicative minimum selection rank of 90 or equivalent with a pass in ATAR English, ATAR Literature or ATAR English as an Additional Languge or Dialect (EALD). Minimum International Baccalaureate (IB) of 33
  • Applicants with Higher Education Study: Other University Studies completed at undergraduate level or higher. A minimum number of 4 subjects with a high credit average is required
  • Refer to Notre Dame general admission criterial:


Legal Practice Board of WA

Related courses

Browse more courses
Is the information on this page correct? Request update
Enquire about this course

Are you currently in Australia?

You must agree before submitting.

Subscribe to our newsletter

Join the conversation